|1-(4-氯苄基)-5-(三氟甲基)-1H-苯并[d]咪唑-2-胺|CsnPharm

CAS No.: 150493-34-8

NS-638 Catalog No. CSN27750

NS-638 is nonpeptide Ca²⁺-channel blocker with IC50 value of 3.4μM for blocking K+-stimulated intracellular Ca²⁺-elevation.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述Calcium influx through ion channels located on the release face of the presynaptic nerve terminal gates the release of neurotransmitters by the fusion of the secretory vesicle and the discharge of its contents^[2]. The flux of calcium ions (Ca2+) into the cytosol, where they serve as intracellular messengers, is regulated by two distinct families of Ca2+ channel proteins. These are the intracellular Ca2+ release channels, which allow Ca2+ to enter the cytosol from intracellular stores, and the plasma membrane Ca2+ channels, which control Ca2+ entry from the extracellular space. The intracellular channels include the large Ca2+ channels ("ryanodine receptors") that participate in cardiac and skeletal muscle excitation-contraction coupling, and smaller inositol trisphosphate (InsP3)-activated Ca2+ channels^[3]. NS-638 is a small nonpeptide molecule with Ca2+-channel blocking properties. K+-stimulated intracellular Ca2+-elevation is blocked with an IC50 value of 3.4 μM. NS-638 dose dependently inhibits K+-stimulated [45 Ca2+]-uptake in chick cortical synaptosomes and 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA)-stimulated [3H]GABA-release from cultured cortical neurons with IC50 values of 2.3 and 4.3 uM, respectively. K+-stimulated intracellular Ca2+-elevation in cultured cerebellar granule cells is equipotently blocked with an IC50 value of 3.4 μM. At this concentration no effect on Ca2+-induced contractions in K+-depolarized guinea pig taenia coli is observed. NS-638 reversibly blocks N- and L-type Ca2+-channels in cultured chick dorsal root ganglion cells in the concentration range of 1-30 μM. In the mouse middle cerebral artery occlusion model, NS-638 administered i.p. (50 mg/kg) at 1 h and 6 h post-ischemia, and once a day for the next two days, results in a 48% reduction in total infarct volume. It does not show protection against ischemic neuronal damage in the gerbil model of bilateral carotid artery occlusion^[4].
参考文献

[1] Møller A, Christophersen P, Drejer J, Axelsson O, Peters D, Jensen LH, Nielsen EO. Pharmacological profile and anti-ischemic properties of the Ca(2+)-channel blocker NS-638. Neurol Res. 1995 Oct;17(5):353-60. PMID: 8584126.
[2] E F Stanley. The calcium channel and the organization of the presynaptic transmitter release face. Trends Neurosci.1997 Sep;20(9):404-9.
[3] A M Katz. Calcium channel diversity in the cardiovascular system. J Am Coll Cardiol. 1996 Aug;28(2):522-9.
[4] A Møller, et al. Pharmacological profile and anti-ischemic properties of the Ca(2+)-channel blocker NS-638. Neurol Res. 1995 Oct;17(5):353-60.

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 3.0702 mL
- 15.3508 mL
- 30.7016 mL
- 5 mM
- 0.6140 mL
- 3.0702 mL
- 6.1403 mL
- 10 mM
- 0.3070 mL
- 1.5351 mL
- 3.0702 mL

技术信息

CAS号

150493-34-8

储存条件

粉末: Keep in dark place,Sealed in dry,2-8°C

液体: -20°C:3-6 月 -80°C:12月

分子式

C15H11ClF3N3

运输

蓝冰

分子量

325.72

别名

溶解度

DMSO	34.0 mg/mL (104.4 mM)

动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

NS-638 Catalog No. CSN27750

靶点选择性

请登录您的专属账户

确认信息